IMVIONIX Acquires BEOVU® Commercial Rights from Novartis
Peachtree Corners, Georgia, USA, November 10, 2026 IMVIONIX Inc. has acquired the exclusive commercial rights to BEOVU® (brolucizumab-dbll) in...
BEOVU
Advertisement
Advertisement
